Extended-spectrum β-lactamases in long-term-care facilities

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 1, 2008, Pages 111-116

  Nicolas Chanoine, Marie Hélène ^a,c   Jarlier, Vincent ^b  

^a BEAUJON HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Faculte de Medecine D Diderot   (France)

Author keywords

CTX M type; Escherichia coli; Extended spectrum lactamases; Long term survey; Long term care facilities; Review

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; PROTEIN CTX M; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ESCHERICHIA COLI; FRANCE; HEALTH CARE FACILITY; HEALTH SURVEY; HOSPITAL BED CAPACITY; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LONG TERM CARE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 37249032359     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01862.x     Document Type: Review

References (15)

1. Muller M, McGeer A, Willey BM et al. Outbreaks of multi-drug resistant Escherichia coli in long-term care facilities in the Durham, York, and Toronto regions of Ontario, 2000-2002. Can Commun Dis Rep 2002; 28: 113-118.
2. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resitant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-523.
3. Cukier L, Lutzler P, Bizien A, Avril JL. Investigation of an epidemic of an extended spectrum beta-lactamase producing Escherichia coli in a geriatric department. Pathol Biol 1999; 47: 440-444.
4. Ma L, Matsuo H, Ishii Y, Yamaguchi K. Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals. J Infect Chemother 2002; 8: 155-162.
5. Romero L, Lopez L, Rodriguez-Bano J, Ramon-Hernandez J, Martinez-Martinez L, Pascual A. Long-term study of frequency of Escherichia coli and Kebsiella pneumoniae isolates producing extended-spectrum β-lactamases. Clin Microbiol Infect 2005; 11: 625-631.
6. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-3742.
7. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24: 17-22.
8. Einhorn AE, Pharm D, Neuhauser MM et al. Extended-spectrum β-lactamases: Frequency, risk factors, and outcomes. Pharmacotherapy 2002; 22: 14-20.
9. Kassis-Chikhani N, Vimont S, Asselat K et al. CTX-M beta-lactamase-producing Escherichia coli in long-term care facilities, France. Emerg Infect Dis 2004; 10: 1697-1698.
10. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
11. Comitéde l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2006 http://www.sfm.asso.fr.
12. Maslow JN, Lautenbach E, Glaze T, Bilker W, Johnson JR. Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother 2004; 48: 3618-3620.
13. Horcajada JP, Soto S, Gajewskia X et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic groupB2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43: 2962-2964.
14. Drews SJ, Poutanen SM, Mazzulli T et al. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005; 43: 4218-4220.
15. Leflon-Guibout V, Bonacorsi S, Clermont O, Ternat G, Heym B, Nicolas-Chanoine MH. Pyelonephritis caused by multiple clones of Escherichia coli, susceptible and resistant to co-amoxiclav, after a 45 day course of co-amoxiclav. J Antimicrob Chemother 2002; 49: 373-377.